東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacological treatment of Alzheim...

Santos, Gustavo Alves Andrade dos.

FindBook

Google Book

Amazon

博客來

Pharmacological treatment of Alzheimer's disease = scientific and clinical aspects /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacological treatment of Alzheimer's disease/ edited by Gustavo Alves Andrade dos Santos.
其他題名:	scientific and clinical aspects /
其他作者:	Santos, Gustavo Alves Andrade dos.
出版者:	Cham :Springer International Publishing : : 2022.,
面頁冊數:	xiv, 231 p. :ill. (some col.), digital ;24 cm.
內容註:	1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer's Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
Contained By:	Springer Nature eBook
標題:	Alzheimer's disease - Chemotherapy. -
電子資源:	https://doi.org/10.1007/978-3-030-94383-7
ISBN:	9783030943837

Pharmacological treatment of Alzheimer's disease = scientific and clinical aspects /
Pharmacological treatment of Alzheimer's diseasescientific and clinical aspects /[electronic resource] :edited by Gustavo Alves Andrade dos Santos. - Cham :Springer International Publishing :2022. - xiv, 231 p. :ill. (some col.), digital ;24 cm.

1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer's Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.

Alzheimer's disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer's disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer's disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer's disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer's disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.

ISBN: 9783030943837

Standard No.: 10.1007/978-3-030-94383-7doiSubjects--Topical Terms:

660091
Alzheimer's disease
--Chemotherapy.

LC Class. No.: RC523 / .P53 2022

Dewey Class. No.: 616.8311061

Pharmacological treatment of Alzheimer's disease = scientific and clinical aspects /
LDR:02875nmm a2200325 a 4500 001 2299239
003 DE-He213
005 20220325084542.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030943837 $q (electronic bk.)
020 $a 9783030943820 $q (paper)
024 7 $a 10.1007/978-3-030-94383-7 $2 doi
035 $a 978-3-030-94383-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523 $b .P53 2022
072 7 $a MJX $2 bicssc
072 7 $a MED032000 $2 bisacsh
072 7 $a MKN $2 thema
082 0 4 $a 616.8311061 $2 23
090 $a RC523 $b .P536 2022
245 0 0 $a Pharmacological treatment of Alzheimer's disease $h [electronic resource] : $b scientific and clinical aspects / $c edited by Gustavo Alves Andrade dos Santos.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xiv, 231 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1. Introduction -- 2. Principles of Pharmacology in Dementia -- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease -- 4. The Use of Esterase Inhibitors -- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer's Disease -- 6. Supportive Pharmacological Treatment -- 7. Herbal Medicines and Supplements -- 8. Emergency Situations -- 9. Relationships between Treatment and Clinical Evaluations -- 10. New Perspectives for Treatment in Alzheimer's Disease.
520 $a Alzheimer's disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer's disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer's disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer's disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer's disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
650 0 $a Alzheimer's disease $x Chemotherapy. $3 660091
650 1 4 $a Geriatrics. $3 626777
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Psychiatry. $3 517037
700 1 $a Santos, Gustavo Alves Andrade dos. $3 3596566
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-94383-7
950 $a Medicine (SpringerNature-11650)